PEAK6
XBI icon

PEAK6’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

PEAK6’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.9M Sell
140,000
-494,300
-78% -$61.7M 0.04% 384
2025
Q4 		$77.3M Buy
634,300
+152,600
+32% +$17.5M 0.14% 121
2025
Q3 		$48.3M Sell
481,700
-146,500
-23% -$13.2M 0.07% 213
2025
Q2 		$52.1M Sell
628,200
-197,700
-24% -$15.8M 0.1% 178
2025
Q1 		$67M Sell
825,900
-347,500
-30% -$31.1M 0.15% 114
2024
Q4 		$106M Buy
+1,173,400
New +$114M 0.22% 81

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PEAK6's XBI Position: Q3 2025 in Review

PEAK6 sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 118,991 shares — an estimated $10.7M sold.

PEAK6 first reported a position in XBI in Q4 2024 and held it in 3 quarters. The position peaked at $9.87M in Q2 2025. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • PEAK6 reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
  • PEAK6 sold 118,991 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $10.7M.
  • PEAK6 first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and held it in 3 quarters.
  • PEAK6's State Street SPDR S&P Biotech ETF position peaked at $9.87M in Q2 2025.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on PEAK6's 13F filing for Q3 2025, filed 14 Nov 2025.